{"id":3626,"date":"2022-09-01T16:30:52","date_gmt":"2022-09-01T08:30:52","guid":{"rendered":"http:\/\/www.sinotau.com\/homepage\/"},"modified":"2025-05-29T10:47:26","modified_gmt":"2025-05-29T02:47:26","slug":"homepage","status":"publish","type":"page","link":"https:\/\/www.sinotau.com\/en\/","title":{"rendered":"Home page"},"content":{"rendered":"\n<section class=\"page page-home-s1\"><video class=\"vid\" src=\"\/wp-content\/uploads\/2024\/05\/\u5148\u901a\u9996\u9875\u89c6\u9891.mp4\" poster=\"\/wp-content\/themes\/qnz\/assets\/img\/banners\/slider01.jpg\" autoplay=\"\" muted=\"\" loop=\"\" webkit-playsinline=\"true\" playsinline=\"true\" x-webkit-airplay=\"allow\" x5-video-player-type=\"h5\" x5-video-player-fullscreen=\"true\" x5-video-orientation=\"portraint\"><\/video><div class=\"txt-container\">\n        <div class=\"container\">    \n          <div class=\"text20\">                        <\/div>\n          <h2 class=\"text60\">Invent radiopharmaceuticals for lives <\/h2>\n          <div class=\"text32 mb-media-3\">Lays out  <strong>oncology , neurology and cardiology<\/strong> <\/div>\n          <div class=\"go\"> <a href=\"http:\/\/www.sinotau.com\/en\/products\/\">Products<i class=\"iconfont icon-right\"><\/i><\/a><\/div>\n        <\/div>\n      <\/div>\n    <\/section>\n\n\n<section class=\"page page-home-s2\">\n<div class=\"row g-0 align-items-center\">\n<div class=\"col-md-6\">\n<div class=\"left_col wow fadeInUp\">\n<div class=\"sub_title\">Who We Are?<\/div>\n<h2 class=\"title text32 mb-media-3\">A company ahead of the innovative radiopharmaceuticals in China.<\/h2>\n<p class=\"des mb-media-3\">Since 2014, Sinotau started the R&amp;D of next-generation radiopharmaceuticals,which is an innovative pharmaceutical company specializing in the R&amp;D, production, clinical application and marketing of radiopharmaceuticals<\/p>\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/about\/\">About Sinotau<\/a><\/div>\n<\/div>\n<\/div>\n<div class=\"col-md-6\">\n<div class=\"right_col wow fadeInUp pt-media-5 pb-media-5\">\n<div class=\"data\">\n<div class=\"row\">\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">9<\/div>\n<p>Year+<\/p>\n<\/div>\n<div class=\"des\">Years of radiopharmaceutical R&amp;D<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">100<\/div>\n<p>%<\/p>\n<\/div>\n<div class=\"des\">Focus on radiopharmaceuticals<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">1<\/div>\n<p>\u00a0<\/p>\n<\/div>\n<div class=\"des\">Radiopharmaceutical Product<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">10<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Pipeline<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">5<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">R&amp;D and production sites<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">400<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Skilled employees<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">80<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Authorized Patent<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section class=\"page page-home-s3\">\n<div class=\"row g-0 align-items-lg-center\">\n<div class=\"col-md\">\n<div class=\"bg\">\n<div class=\"pic\"><img decoding=\"async\" src=\"\/wp-content\/themes\/qnz\/assets\/img\/nb_02.jpg\" alt=\"Radiopharmaceutical Structure\" \/>\n<div class=\"dot\" style=\"z-index: 300;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Chelate<\/h4>\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 75%; top: 64%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Linker<\/h4>\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 85%; top: 65%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Radioisotopes<\/h4>\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 36.5%; top: 85%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Targeting Molecule<\/h4>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-md\">\n<div class=\"right_col wow fadeInUp\">\n<div class=\"sub_title\">Innovation<\/div>\n<h2 class=\"title text32\">From precise diagnostics to targeted therapies, we pioneer next-generation solutions helping improve therapeutic outcomes and the lives of patients.<\/h2>\n<p class=\"des\">Sinotau has established differentiated and highly competitive pipeline out of high attention of the R&amp;D innovation and for the sustainable development and theranostic radiopharmaceuticals with the characteristic and diverse innovation ability of our own team.<\/p>\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/innovating\/\">Pipeline<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column page page-home-s4 is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"news-header\">\n<div class=\"row align-items-center mb-media-2\">\n<div class=\"col-md\">\n<div class=\"title-section wow fadeInUp\">\n<h4 class=\"sub_title\">News<\/h4>\n<h3 class=\"title text32\">Sinotau is totally engrossed in research and development of radiopharmaceuticals. Learn about our latest progress.<\/h3>\n<\/div>\n<\/div>\n<div class=\"col-md-auto\">\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/category\/company-news\/\">Read More<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"news-list\"><div class=\"swiper newsSliders\"><div class=\"swiper-wrapper\"><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"https:\/\/www.sinotau.com\/en\/2025\/10\/top-oncology-journal-esmo-lba-concurrent-release-xtr008-receives-international-top-level-dual-endorsement\/\"><h3 class=\"title\">Top Oncology Journal &amp; ESMO LBA Concurrent Release: XTR008 Receives International Top-Level Dual Endorsement<\/h3><p class=\"des\">Sinotau is pleased to announce that the results of the Phase III clinical trial in China for our self-developed radionuclide therapeutic drug, \u00b9\u2077\u2077Lu-Dotatate(XTR008), have been officially published in the prestigious international oncology journal&nbsp;Annals of Oncology&nbsp;(Impact Factor: 65.4). Concurrently, the latest analysis results from this study were successfully selected as a Late-Breaking Abstract (LBA) for this [&hellip;]<\/p><div class=\"date\">2025-10-20<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"https:\/\/www.sinotau.com\/en\/2025\/10\/sinotau-selected-as-inaugural-member-unit-of-national-cardiovascular-imaging-committee\/\"><h3 class=\"title\">Sinotau\u00a0Selected as Inaugural Member Unit of National Cardiovascular Imaging Committee<\/h3><p class=\"des\">Recently, the Cardiovascular Imaging Professional Committee of the National Expert Committee on Cardiovascular Diseases&nbsp;was officially established. Initiated by experts including Academician Hu Shengshou and with Academician Wang Zhenchang serving as its first Chairman, the committee brings together hundreds of top experts in the field of cardiovascular imaging in China. Its establishment marks a new stage [&hellip;]<\/p><div class=\"date\">2025-10-10<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"https:\/\/www.sinotau.com\/en\/2025\/09\/eanm-2025-100-acceptance-rate-sinotau-self-innovated-research-results-selected-as-top-rated-oral-presentations\/\"><h3 class=\"title\">EANM 2025 | 100% Acceptance Rate: Sinotau&#8217; Self-Innovated Research Results\u00a0Selected as Top Rated Oral Presentations<\/h3><p class=\"des\">The Annual Congress of the European Association of Nuclear Medicine (EANM), a top-tier academic conference in the global nuclear medicine field, will take place at the International Conference Centre in&nbsp;Barcelona, Spain on&nbsp;October 4-8, 2025.&nbsp;Focusing on cutting-edge topics in nuclear medicine, the EANM Congress is renowned for setting international clinical practice standards, and the guidelines it [&hellip;]<\/p><div class=\"date\">2025-09-29<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"https:\/\/www.sinotau.com\/en\/2025\/09\/innovative-radiopharmaceutical-xtr020-completes-enrollment-anddosing-of-all-subjects-in-chinese-phase-iii-clinical-study\/\"><h3 class=\"title\">Innovative Radiopharmaceutical XTR020 Completes Enrollment andDosing of All Subjects in Chinese Phase III Clinical Study<\/h3><p class=\"des\">Beijing, China \u2014Beijing Sinotau International Pharmaceutical Technology Co. , Ltd.&nbsp;is pleased to announce that the innovative radiopharmaceutical XTR020 for prostate cancer diagnosis has recently completed the enrollment and dosing of all subjects in its Phase III clinical study in China, marking a significant milestone in the product\u2019s research and development in China. Despite clear and [&hellip;]<\/p><div class=\"date\">2025-09-24<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"https:\/\/www.sinotau.com\/en\/2025\/09\/esmo-2025-xtr008-china-phase-iii-study-results-was-selected-for-esmo-2025-lba\/\"><h3 class=\"title\">ESMO 2025 | XTR008 China Phase III Study Results was Selected for ESMO 2025 LBA<\/h3><p class=\"des\">October 17-21, 2025\u2013 The European Society for Medical Oncology (ESMO) Congress, Europe&#8217;s most influential oncology conference, will be held in Berlin, Germany. The full results of the China Phase III registration clinical trial for Sinotau&#8217;s self-developed innovative radioconjugate (RDC) drug, XTR008, have been successfully selected as a Late-Breaking Abstract (LBA) and will be globally presented [&hellip;]<\/p><div class=\"date\">2025-09-23<\/div><\/a><\/div><\/div><div class=\"swiper-pagination\"><\/div><\/div><\/div>\n<\/div>\n<\/div>\n\n\n<section class=\"page page-home-s5 pt-media-9 pb-media-9\">\n<div class=\"container\">\n<div class=\"job wow fadeInLeft\">\n<h4 class=\"sub_title\">Talent Development<\/h4>\n<div class=\"des text32 mb-media-3\">We hope to <strong>invent radiopharmaceuticals for lives<\/strong> with you following the same <strong>heart and ideal<\/strong>. It&#8217;s a job, and moreover, it&#8217;s common endeavour.<\/div>\n<div class=\"go\"><a href=\"http:\/\/www.sinotau.com\/en\/join\/\">Join Us<i class=\"iconfont icon-right\"><\/i><\/a><\/div>\n<\/div>\n<\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>Invent radiopharmaceuticals for lives Lays out oncology , neurology and cardiology Products Who We Are? A company ahead of the innovative radiopharmaceuticals in China. Since 2014, Sinotau started the R&amp;D of next-generation radiopharmaceuticals,which is an innovative pharmaceutical company specializing in the R&amp;D, production, clinical application and marketing of radiopharmaceuticals About Sinotau 9 Year+ Years of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3626","page","type-page","status-publish","hentry"],"meta_box":{"salary":[],"career":[]},"_links":{"self":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/comments?post=3626"}],"version-history":[{"count":46,"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626\/revisions"}],"predecessor-version":[{"id":4756,"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626\/revisions\/4756"}],"wp:attachment":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/media?parent=3626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}